Effects of Noninvasive Brain Stimulation on Language Networks and Recovery in Early Poststroke Aphasia

  • Alexander Thiel
    From the Department of Neurology and Neurosurgery, McGill University, Montreal, Canada (A.T., C.A.); Max Planck Institute for Neurological Research, Cologne, Germany (L.K., N.W., J.K., W.-D.H.); RehaNova GmbH, Cologne, Germany (A.H., I.R.-F., T.R.); and Cornell University, New York, NY (N.W.).
  • Alexander Hartmann
    From the Department of Neurology and Neurosurgery, McGill University, Montreal, Canada (A.T., C.A.); Max Planck Institute for Neurological Research, Cologne, Germany (L.K., N.W., J.K., W.-D.H.); RehaNova GmbH, Cologne, Germany (A.H., I.R.-F., T.R.); and Cornell University, New York, NY (N.W.).
  • Ilona Rubi-Fessen
    From the Department of Neurology and Neurosurgery, McGill University, Montreal, Canada (A.T., C.A.); Max Planck Institute for Neurological Research, Cologne, Germany (L.K., N.W., J.K., W.-D.H.); RehaNova GmbH, Cologne, Germany (A.H., I.R.-F., T.R.); and Cornell University, New York, NY (N.W.).
  • Carole Anglade
    From the Department of Neurology and Neurosurgery, McGill University, Montreal, Canada (A.T., C.A.); Max Planck Institute for Neurological Research, Cologne, Germany (L.K., N.W., J.K., W.-D.H.); RehaNova GmbH, Cologne, Germany (A.H., I.R.-F., T.R.); and Cornell University, New York, NY (N.W.).
  • Lutz Kracht
    From the Department of Neurology and Neurosurgery, McGill University, Montreal, Canada (A.T., C.A.); Max Planck Institute for Neurological Research, Cologne, Germany (L.K., N.W., J.K., W.-D.H.); RehaNova GmbH, Cologne, Germany (A.H., I.R.-F., T.R.); and Cornell University, New York, NY (N.W.).
  • Nora Weiduschat
    From the Department of Neurology and Neurosurgery, McGill University, Montreal, Canada (A.T., C.A.); Max Planck Institute for Neurological Research, Cologne, Germany (L.K., N.W., J.K., W.-D.H.); RehaNova GmbH, Cologne, Germany (A.H., I.R.-F., T.R.); and Cornell University, New York, NY (N.W.).
  • Josef Kessler
    From the Department of Neurology and Neurosurgery, McGill University, Montreal, Canada (A.T., C.A.); Max Planck Institute for Neurological Research, Cologne, Germany (L.K., N.W., J.K., W.-D.H.); RehaNova GmbH, Cologne, Germany (A.H., I.R.-F., T.R.); and Cornell University, New York, NY (N.W.).
  • Thomas Rommel
    From the Department of Neurology and Neurosurgery, McGill University, Montreal, Canada (A.T., C.A.); Max Planck Institute for Neurological Research, Cologne, Germany (L.K., N.W., J.K., W.-D.H.); RehaNova GmbH, Cologne, Germany (A.H., I.R.-F., T.R.); and Cornell University, New York, NY (N.W.).
  • Wolf-Dieter Heiss
    From the Department of Neurology and Neurosurgery, McGill University, Montreal, Canada (A.T., C.A.); Max Planck Institute for Neurological Research, Cologne, Germany (L.K., N.W., J.K., W.-D.H.); RehaNova GmbH, Cologne, Germany (A.H., I.R.-F., T.R.); and Cornell University, New York, NY (N.W.).

説明

<jats:sec> <jats:title>Background and Purpose—</jats:title> <jats:p>Modulation of activity in language networks using repetitive transcranial magnetic stimulation (rTMS) may possibly support recovery from poststroke aphasia. Case series and feasibility studies seem to indicate a therapeutic effect; however, randomized sham-controlled, proof-of-principle studies relating clinical effects to activation patterns are missing.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods—</jats:title> <jats:p>Twenty-four patients with subacute poststroke aphasia were randomized to a 10-day protocol of 20-minute inhibitory 1 Hz rTMS over the right triangular part of the posterior inferior frontal gyrus or sham stimulation, followed by 45 minutes of speech and language therapy. Activity in language networks was measured with O-15-water positron emission tomography during verb generation before and after treatment. Language performance was assessed using the Aachen Aphasia Test battery.</jats:p> </jats:sec> <jats:sec> <jats:title>Results—</jats:title> <jats:p> The primary outcome measure, global Aachen Aphasia Test score change, was significantly higher in the rTMS group ( <jats:italic>t</jats:italic> test, <jats:italic>P</jats:italic> =0.003). Increases were largest for subtest naming ( <jats:italic>P</jats:italic> =0.002) and tended to be higher for comprehension, token test, and writing ( <jats:italic>P</jats:italic> <0.1). Patients in the rTMS group activated proportionally more voxels in the left hemisphere after treatment than before (difference in activation volume index) compared with sham-treated patients ( <jats:italic>t</jats:italic> test, <jats:italic>P</jats:italic> =0.002).There was a moderate but significant linear relationship between activation volume index change and global Aachen Aphasia Test score change ( <jats:italic>r</jats:italic> <jats:sup>2</jats:sup> =0.25; <jats:italic>P</jats:italic> =0.015). </jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions—</jats:title> <jats:p>Ten sessions of inhibitory rTMS over the right posterior inferior frontal gyrus, in combination with speech and language therapy, significantly improve language recovery in subacute ischemic stroke and favor recruitment of left-hemispheric language networks.</jats:p> </jats:sec>

収録刊行物

  • Stroke

    Stroke 44 (8), 2240-2246, 2013-08

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ